Search alternatives:
progress decrease » progressive decrease (Expand Search), problems decreased (Expand Search)
increase decrease » increased release (Expand Search), increased crash (Expand Search)
progress decrease » progressive decrease (Expand Search), problems decreased (Expand Search)
increase decrease » increased release (Expand Search), increased crash (Expand Search)
-
1641
Data Sheet 1_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf
Published 2025“…The addition of ruxolitinib increases UCB-Treg cell persistence in peripheral blood in vivo and decreases the soluble form of human inflammatory cytokines including IFN-γ, TNF-α, and sCD40L in plasma along with improvement of skin lesions in SLE xenografts. …”
-
1642
-
1643
-
1644
-
1645
-
1646
-
1647
-
1648
-
1649
-
1650
-
1651
-
1652
-
1653
-
1654
-
1655
-
1656
-
1657
-
1658
-
1659
-
1660